SCHEMBL30717620

SCHEMBL30717620

CC(C)(C)CC(=O)N1CCc2nc(N3CCNCC3)sc2C1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
GRM5 P41594 8/20 0.40
OGA O60502 2/20 0.39
DPP4 P27487 3/20 0.34
DPP8 Q6V1X1 3/20 0.34
DPP9 Q86TI2 3/20 0.34
DPP7 Q9UHL4 3/20 0.34
CHEK1 O14757 1/20 0.33
HRH4 Q9H3N8 1/20 0.32
GRAMD1A Q96CP6 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30717355 0.85 NPC1 (0.43) NPC1RAB9AGRM5OGADPP4
SCHEMBL30717561 0.83 GRAMD1A (0.43) NPC1RAB9AGRM5OGAGRAMD1A
SCHEMBL30717419 0.81 NPC1 (0.39) NPC1RAB9AGRM5OGADPP4
SCHEMBL31748855 0.80 ADORA2A (0.47) NPC1RAB9AGRM5OGAKDM4E
SCHEMBL13494234 0.79 DPP4 (0.49) NPC1RAB9AGRM5DPP4DPP8
SCHEMBL30717362 0.75 L3MBTL1 (0.50) NPC1RAB9AGRM5OGADPP4
SCHEMBL30790972 0.74 HTR2C (0.50) GRM5CHEK1HRH4KDM4EALDH1A1
SCHEMBL4590227 0.72 MEN1 (0.48) NPC1RAB9AGRM5ALDH1A1GAA
SCHEMBL30717407 0.72 CNR2 (0.35) NPC1RAB9AGRM5DPP4DPP8
SCHEMBL30717312 0.72 NPC1 (0.39) NPC1RAB9AGRM5OGADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388604-A1 Compounds and Their Use as PDE4 Activators MIRONID LIMITED (GB) 2025-12-25 US claimed
US-20250388604-A1 Compounds and Their Use as PDE4 Activators MIRONID LIMITED (GB) 2025-12-25 US disclosed
EP-4572762-A1 COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS Mironid Limited (GB) 2025-06-25 EP disclosed
WO-2024038128-A1 COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS MIRONID LIMITED (GB) 2024-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388604-A1 Compounds and Their Use as PDE4 Activators PDE4A, PDE7A, PDE4B NPC1 3054/4885RAB9A 701/4885GRM5 2029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.